| For: | Han LL, Wang SH, Yao MY, Zhou H. Urinary exosomal microRNA-145-5p and microRNA-27a-3p act as noninvasive diagnostic biomarkers for diabetic kidney disease. World J Diabetes 2024; 15(1): 92-104 [PMID: 38313849 DOI: 10.4239/wjd.v15.i1.92] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i1/92.htm |
| Number | Citing Articles |
| 1 |
Jiangyuan Jin, Mianzhi Zhang. Research progress on the role of extracellular vesicles in the pathogenesis of diabetic kidney disease. Renal Failure 2024; 46(1) doi: 10.1080/0886022X.2024.2352629
|
| 2 |
Yixuan Fang, Shiyi Sun, Jing Wu, Guanjian Liu, Qinqin Wu, Xingwu Ran. Alterations in the Levels of Urinary Exosomal MicroRNA-183-5p and MicroRNA-125a-5p in Individuals with Type 2 Diabetes Mellitus. Biomedicines 2024; 12(11): 2608 doi: 10.3390/biomedicines12112608
|
| 3 |
Haiying Zhang, Yubo Jiang, Jun Song, Shaoqing Wang, Jianhong Lu, Fuxin Wei, Xiu Li. Urinary exosomes exacerbate diabetic kidney disease by promoting NLRP3 inflammasome activation via the microRNA-516b-5p/SIRT3/AMPK pathway. American Journal of Physiology-Endocrinology and Metabolism 2025; 328(6): E911 doi: 10.1152/ajpendo.00527.2024
|
| 4 |
Anupriya Baranwal, Vipul Bansal, Ravi Shukla. Emerging Biomarkers and Nanobiosensing Strategies in Diabetes. Biosensors 2025; 15(10): 639 doi: 10.3390/bios15100639
|
| 5 |
Li Xu, Xiuli Guo, Wen Gan, Linhong Yao, Jianing Wang, Qi Li, Qiuling Fan. Diagnostic value of the correlation between urinary MDM2 and podocyte mitotic catastrophe in diabetic kidney disease. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01856-9
|
| 6 |
Shaimaa I. Barr, Eman M. Abd El-Azeem, Sahar S. Bessa, Tarek M. Mohamed. Role of exosomes in pathogenesis, diagnosis, and treatment of diabetic nephropathy. BMC Nephrology 2025; 26(1) doi: 10.1186/s12882-025-04120-4
|
| 7 |
Yang Yu, Yunjie Shan, Anjie Ding, Hui Qian. Extracellular vesicles in diabetic kidney disease: Emerging mechanisms, therapeutic implications, and biomarker prospects. Biochemical Pharmacology 2026; 244: 117605 doi: 10.1016/j.bcp.2025.117605
|
| 8 |
Shiyuan Huang, Fang Yan, Yi Qiu, Tao Liu, Wenjin Zhang, Yige Yang, Rao Zhong, Yang Yang, Xi Peng. Exosomes in inflammation and cancer: from bench to bedside applications. Molecular Biomedicine 2025; 6(1) doi: 10.1186/s43556-025-00280-9
|
| 9 |
Guido Gembillo, Luca Soraci, Rossella Messina, Lorenzo Lo Cicero, Giuseppe Spadaro, Felicia Cuzzola, Michela Calderone, Maria Federica Ricca, Simona Di Piazza, Flavia Sudano, Luigi Peritore, Domenico Santoro. Urinary biomarkers of diabetic kidney disease. World Journal of Diabetes 2026; 17(1): 110502 doi: 10.4239/wjd.v17.i1.110502
|
| 10 |
Asif Mondal, Sucharita Banerjee, Somnath Naskar, Chiranjit Bose, Chinmay Saha, Subhasish Pramanik, Bidisha Mukherjee, Piyali Jati, Pranab Kumar Sahana, Rayaz A. Malik, Satinath Mukhopadhyay. miR‐27a‐3p Upregulation and Netrin‐1 Deficiency Drive Inflammatory Responses and Nerve Degeneration in Patients With Diabetes. European Journal of Neurology 2025; 32(12) doi: 10.1111/ene.70449
|
| 11 |
Md. Sohanur Rahman, Suvankar Ghorai, Kingshuk Panda, Maria J. Santiago, Saurabh Aggarwal, Ting Wang, Irfan Rahman, Srinivasan Chinnapaiyan, Hoshang J. Unwalla. Dr. Jekyll or Mr. Hyde: The multifaceted roles of miR-145-5p in human health and disease. Non-coding RNA Research 2025; 11: 22 doi: 10.1016/j.ncrna.2024.11.001
|
| 12 |
Yimo Huang, Wende Ma, Cen Guo, Xiaoling Su. Mechanism of action and potential therapeutic targets of TGF-β-related signaling pathway and its downstream miRNA expression in pulmonary arterial hypertension. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1596767
|
| 13 |
Miao Hu, Yi Deng, Zhen Weng, Yujie Bai, Jiayan Zhang, Jianzhong Li, Lei Shen, Xiahong Shen, Ling Zhou. Expression and clinical significance of platelet-derived miR-145-5p and miR-6805-3p in diabetic kidney disease patients. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1529759
|
| 14 |
Huanhuan Cao, Zixi Li, Jiajia Ye, Yi Lv, Chun Zhang, Tao Liang, Yumei Wang. Emerging roles of exosomes in the diagnosis and treatment of kidney diseases. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1525314
|
| 15 |
Bhavana Bagdaram Choudhary, Bhupendra Puri, Anil Bhanudas Gaikwad. Novel molecular biomarkers in kidney diseases: bridging the gap between early detection and clinical implementation. Journal of Pharmacy and Pharmacology 2025; doi: 10.1093/jpp/rgaf096
|
